PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+20.2%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$4.36B
AUM Growth
+$4.36B
(+23%)
Cap. Flow
+$460M
Cap. Flow
% of AUM
10.56%
Top 10 Holdings %
Top 10 Hldgs %
53.12%
Holding
126
New
23
Increased
23
Reduced
17
Closed
18
Top Buys
| 1 |
BridgeBio Pharma
BBIO
|
$181M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$179M |
| 3 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
$90.3M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$46.7M |
| 5 |
Zymeworks
ZYME
|
$39.5M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$148M |
| 2 |
Ascendis Pharma
ASND
|
$73.7M |
| 3 |
NVTA
Invitae Corporation
NVTA
|
$19.5M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$17.3M |
| 5 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$16.4M |
Sector Composition
| 1 | Healthcare | 93.53% |
| 2 | Financials | 0.76% |
| 3 | Technology | 0.14% |
| 4 | Consumer Discretionary | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
ADMA Biologics
ADMA
$4.03B
| $44.6M | 1.02% |
11,521,102
+5,000,000
| +77% | +$19.3M |
|
27
Allogene Therapeutics
ALLO
$249M
| $41.5M | 0.95% |
1,543,790
| – | – |
|
28
Verrica Pharmaceuticals
VRCA
$49.4M
| $39.6M | 0.91% |
3,410,412
| – | – |
|
29
Kodiak Sciences
KOD
$453M
| $36.7M | 0.84% |
3,135,199
| – | – |
|
|
MNTA
30
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $36.2M | 0.83% |
2,905,000
+30,000
| +1% | +$373K |
|
|
ONCE
31
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $35.8M | 0.82% |
+350,000
| New | +$35.8M |
|
32
CytomX Therapeutics
CTMX
$350M
| $35.4M | 0.81% |
3,153,923
-20,000
| -0.6% | -$224K |
|
33
eHealth
EHTH
$126M
| $33.2M | 0.76% |
385,982
+96,125
| +33% | +$8.28M |
|
|
VAPO
34
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $32.3M | 0.74% |
1,404,470
+158,155
| +13% | +$3.64M |
|
|
NVTA
35
DELISTED
Invitae Corporation
NVTA
| $31.6M | 0.72% |
1,343,491
-828,427
| -38% | -$19.5M |
|
|
NEPT
36
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $30M | 0.69% |
8,891,452
| – | – |
|
|
DBVT
37
DBV Technologies
DBVT
$249M
| $29.7M | 0.68% |
3,609,084
+2,480,560
| +220% | +$20.4M |
|
38
Rocket Pharmaceuticals
RCKT
$358M
| $29.7M | 0.68% |
1,977,412
+1,519,239
| +332% | +$22.8M |
|
39
Establishment Labs
ESTA
$1.11B
| $27.7M | 0.64% |
1,260,528
+646,286
| +105% | +$14.2M |
|
|
CBAY
40
DELISTED
Cymabay Therapeutics
CBAY
| $27.7M | 0.63% |
3,862,821
-350,000
| -8% | -$2.51M |
|
|
KDMN
41
DELISTED
Kadmon Holdings, Inc.
KDMN
| $27.1M | 0.62% |
13,165,746
| – | – |
|
|
CNCE
42
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $26.5M | 0.61% |
2,204,641
| – | – |
|
|
VBIV
43
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $24.6M | 0.56% |
25,951,556
+2,000,000
| +8% | +$1.9M |
|
44
Solid Biosciences
SLDB
$448M
| $22.6M | 0.52% |
+3,927,222
| New | +$22.6M |
|
45
uniQure
QURE
$954M
| $22M | 0.51% |
281,820
+50,000
| +22% | +$3.91M |
|
|
EIDX
46
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $21.3M | 0.49% |
686,992
| – | – |
|
47
Teladoc Health
TDOC
$1.37B
| $20.4M | 0.47% |
307,021
-187,979
| -38% | -$12.5M |
|
48
Stoke Therapeutics
STOK
$1.08B
| $19.6M | 0.45% |
+671,978
| New | +$19.6M |
|
49
Aldeyra Therapeutics
ALDX
$350M
| $18.5M | 0.42% |
3,085,458
| – | – |
|
|
TPTX
50
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $17.3M | 0.4% |
+424,968
| New | +$17.3M |
|